From my watchlist: AVEO +65%, MBOT +8%:
AVEO- Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma
MBOT Medical robots field, one of the hottest technology spaces,almost zero debt&deficit,financing done.
looking solid picks.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.